| Product NDC: | 0024-4142 |
| Proprietary Name: | Multaq |
| Non Proprietary Name: | Dronedarone |
| Active Ingredient(s): | 400 mg/1 & nbsp; Dronedarone |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0024-4142 |
| Labeler Name: | sanofi-aventis U.S. LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022425 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20090701 |
| Package NDC: | 0024-4142-50 |
| Package Description: | 500 TABLET, FILM COATED in 1 BOTTLE (0024-4142-50) |
| NDC Code | 0024-4142-50 |
| Proprietary Name | Multaq |
| Package Description | 500 TABLET, FILM COATED in 1 BOTTLE (0024-4142-50) |
| Product NDC | 0024-4142 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Dronedarone |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20090701 |
| Marketing Category Name | NDA |
| Labeler Name | sanofi-aventis U.S. LLC |
| Substance Name | DRONEDARONE |
| Strength Number | 400 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Antiarrhythmic [EPC] |